Skip to main content
HeartCited

Berberine para Metabolic Syndrome (Cardiovascular Aspects)

B Evidências Pelo menos um ensaio aleatorizado apoia esta conclusão, com resultados maioritariamente consistentes.

Improves multiple metabolic parameters: glucose, lipids, BMI, waist circumference. AMPK activation addresses insulin resistance — the core driver of metabolic syndrome.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dmetabolic\u002Dsyndrome\u002Dcardiovascular'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Conclusão

Improves multiple metabolic parameters: glucose, lipids, BMI, waist circumference. AMPK activation addresses insulin resistance — the core driver of metabolic syndrome.

Key Study Findings

Other 6 weeks
Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila.
Dose: None vs: MCD diet MASH model; Abx + FMT experiments Outcome: Hepatic/colonic inflammation, Akkermansia abundance Efeito: None None

População: MCD diet-induced MASH C57BL/6J male mice

Systematic Review n=61
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Dose: None vs: None Outcome: None Efeito: None None

População: Alzheimer's disease patients

Key Statistics

20

Estudos

2500

Participantes

Positive

B

Nota

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

general:
500-1,500 mg/day divided TID
lipidsupport:
500 mg TID with meals

Limite superior: Not formally established; GI side effects limit doses >1,500 mg/day

Dosagens Estudadas em Pesquisas

Dosagem Duração Efeito N
None 6 weeks Positive --
None -- Mixed --
None -- Positive 61

Melhor horário: With meals, divided TID for sustained plasma levels; short half-life

Safety & Side Effects

Efeitos Colaterais Relatados

  • Diarrhea (most common, usually resolves in 2 weeks)
  • Constipation
  • Flatulence
  • Abdominal pain
  • May lower blood sugar (monitor in diabetics)

Interações Conhecidas

  • Metformin (additive blood sugar lowering; may increase metformin levels)
  • CYP2D6 and CYP3A4 substrates (berberine is a CYP inhibitor)
  • Cyclosporine (may increase blood levels)
  • Macrolide antibiotics (may prolong QT interval)
  • Statins (complementary mechanism; monitor for additive effects)

Ingestão máxima tolerável: Not formally established; GI side effects limit doses >1,500 mg/day

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does Berberine help with Metabolic Syndrome (Cardiovascular Aspects)?
Based on 20 studies with 2,500 participants, there is moderate evidence from clinical studies that Berberine may support Metabolic Syndrome (Cardiovascular Aspects) management. Our evidence grade is B (Good Evidence).
How much Berberine should I take for Metabolic Syndrome (Cardiovascular Aspects)?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day divided TID. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea (most common, usually resolves in 2 weeks), Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Metabolic Syndrome (Cardiovascular Aspects)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 2,500 total participants. The overall direction of effect is positive.

References

  1. [1] Jiahui Xu et al.. J Nutr Biochem. 2025. Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila. doi:10.1016/j.jnutbio.2025.110069 PubMed
  2. [2] Yufan Dai et al.. Braz J Med Biol Res. 2022. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in … doi:10.1590/1414-431X2022e12096 PubMed
  3. [3] Noriko Shinjyo et al.. J Integr Med. 2020. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. doi:10.1016/j.joim.2020.01.004 PubMed

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.